Back to NEXTBio Capital Management LP
Q3 2026 13F filing
Updated 9 days ago25 disclosed positions worth $234.4M
Portfolio value
$234.4M
Total holdings
25
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-13
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PROTAGONIST THERAPEUTICS INC | $30.9M | 219.3K | 13.18% | — |
| 2 | S SHATTUCK LABS INC | $25.4M | 3.73M | 10.85% | — |
| 3 | C COMPASS PATHWAYS PLC | $22.1M | 1.78M | 9.43% | — |
| 4 | R RHYTHM PHARMACEUTICALS INC | $12.5M | 131.8K | 5.35% | — |
| 5 | V VOR BIOPHARMA INC | $11.8M | 620.9K | 5.05% | — |
| 6 | P PHARVARIS N V | $11.8M | 372.6K | 5.04% | — |
| 7 | X XENON PHARMACEUTICALS INC | $11.5M | 310.2K | 4.92% | — |
| 8 | Z ZENAS BIOPHARMA INC | $11.5M | 426.7K | 4.91% | — |
| 9 | P PALVELLA THERAPEUTICS INC NE | $11.1M | 80.4K | 4.73% | — |
| 10 | G STRUCTURE THERAPEUTICS INC | $9.8M | 312.5K | 4.17% | — |
| 11 | O ORIC PHARMACEUTICALS INC | $9.2M | 684.5K | 3.93% | — |
| 12 | E ENTERA BIO LTD | $8.5M | 2.92M | 3.63% | — |
| 13 | V VERASTEM INC | $7.3M | 906.7K | 3.11% | — |
| 14 | I INVENTIVA SA | $6.6M | 1.79M | 2.81% | — |
| 15 | Z ZAI LAB LTD | $6.3M | 238.4K | 2.68% | — |
| 16 | P VAXCYTE INC | $6.1M | 107.2K | 2.60% | — |
| 17 | C COGENT BIOSCIENCES INC | $5.7M | 178.0K | 2.43% | — |
| 18 | K KORSANA BIOSCIENCES INC | $5.6M | 175.4K | 2.39% | — |
| 19 | C CRESCENT BIOPHARMA INC. | $5.4M | 372.9K | 2.32% | — |
| 20 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $4.7M | 250.0K | 1.99% | — |
| 21 | I DISC MEDICINE INC | $3.4M | 52.7K | 1.47% | — |
| 22 | L LB PHARMACEUTICALS INC | $2.7M | 69.5K | 1.14% | — |
| 23 | A ADARX PHARMACEUTICALS INC | $2M | 100.0K | 0.85% | — |
| 24 | M MONTE ROSA THERAPEUTICS INC | $1.3M | 111.5K | 0.57% | — |
| 25 | E EVOMMUNE INC | $983K | 119.1K | 0.42% | — |